<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/"><channel><title>PeptideScanner evidence for Degarelix</title><link>https://peptidescanner.com/peptides/degarelix/</link><description>Versioned, source-linked PeptideScanner evidence objects for Degarelix. Selected coverage; not medical advice.</description><language>en-us</language><atom:link href="https://peptidescanner.com/feeds/peptides/degarelix.xml" rel="self" type="application/rss+xml"/><item><title>Development and Validation of a Stability-Indicating HPLC Method for Degarelix and Characterization of Its Degradation Impurities Using LC-MS, 1H NMR, and FTIR Techniques.</title><link>https://peptidescanner.com/stories/pubmed-pmid-43041099-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-43041099-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-43041099-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-11-17. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-17</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00116753</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00116753-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00116753-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00116753-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2010-12-10. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00116779</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00116779-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00116779-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00116779-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2011-12-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00117286</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00117286-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00117286-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00117286-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-12-18. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00117949</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00117949-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00117949-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00117949-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2011-05-23. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00215683</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00215683-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00215683-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00215683-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2015-04-01. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00268892</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00268892-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00268892-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00268892-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2010-12-24. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00295750</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00295750-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00295750-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00295750-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2012-12-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00451958</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00451958-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00451958-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00451958-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2013-03-21. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00468286</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00468286-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00468286-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00468286-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2011-03-23. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00527488</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00527488-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00527488-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00527488-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2015-05-04. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00738673</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00738673-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00738673-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00738673-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2013-01-18. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00801242</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00801242-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00801242-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00801242-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2014-09-03. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00818623</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00818623-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00818623-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00818623-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-11-30. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00819156</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00819156-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00819156-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00819156-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-11-30. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00819247</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00819247-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00819247-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00819247-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2023-11-09. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00947882</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00947882-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00947882-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00947882-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2015-06-08. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT00967018</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct00967018-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct00967018-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct00967018-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2013-01-03. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01071915</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01071915-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01071915-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01071915-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2013-02-12. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01215513</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01215513-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01215513-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01215513-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2013-05-22. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01220869</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01220869-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01220869-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01220869-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-04-13. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01696877</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01696877-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01696877-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01696877-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-03-28. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01731912</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01731912-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01731912-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01731912-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2019-01-18. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT01751451</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct01751451-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct01751451-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct01751451-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-11-19. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02135445</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02135445-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02135445-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct02135445-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2017-04-13. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02489357</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02489357-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02489357-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct02489357-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2021-11-12. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT02849990</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct02849990-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct02849990-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct02849990-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2022-01-13. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03069937</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03069937-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03069937-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct03069937-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2025-10-15. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT03689699</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct03689699-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct03689699-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct03689699-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2026-10-15. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT04397718</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct04397718-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct04397718-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct04397718-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2022-06-06. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>ClinicalTrials.gov record NCT05181800</title><link>https://peptidescanner.com/stories/clinicaltrials-gov-nct05181800-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:clinicaltrials-gov-nct05181800-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#clinicaltrials-gov-nct05181800-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Clinical trials; date in source 2024-09-27. PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.</description><dc:date>2026-11-15</dc:date><category>Clinical trials</category><category>Lifecycle state: current</category></item><item><title>Drugs@FDA application NDA022201</title><link>https://peptidescanner.com/stories/fda-drugs-nda022201/</link><guid isPermaLink="false">urn:peptidescanner:story:fda-drugs-nda022201:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#fda-drugs-nda022201-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2008-12-24. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Federal Register notice 2010-4159</title><link>https://peptidescanner.com/stories/federal-register-2010-4159/</link><guid isPermaLink="false">urn:peptidescanner:story:federal-register-2010-4159:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#federal-register-2010-4159-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Regulatory; date in source 2010-03-01. PeptideScanner reports the cited regulator or label record. It does not extend that record into broader safety, effectiveness, or approval claims.</description><dc:date>2026-11-15</dc:date><category>Regulatory</category><category>Lifecycle state: current</category></item><item><title>Degarelix for prostate cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-19453267-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-19453267-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-19453267-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2009-05-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Degarelix (firmagon) for prostate cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-19838145-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-19838145-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-19838145-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-11-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Degarelix acetate for the treatment of prostate cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-20069136-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-20069136-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-20069136-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-08-04. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Evaluation of degarelix in the management of prostate cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-21188095-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-21188095-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-21188095-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-04-09. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>In vitro studies investigating the interactions between degarelix, a decapeptide gonadotropin-releasing hormone blocker, and cytochrome P450.</title><link>https://peptidescanner.com/stories/pubmed-pmid-21496210-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-21496210-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-21496210-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2014-11-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Metabolite profiles of degarelix, a new gonadotropin-releasing hormone receptor antagonist, in rat, dog, and monkey.</title><link>https://peptidescanner.com/stories/pubmed-pmid-21768273-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-21768273-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-21768273-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-02-12. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Degarelix: an antagonist to GnRH--theoretical and treatment considerations in paraphilia.</title><link>https://peptidescanner.com/stories/pubmed-pmid-22082230-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-22082230-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-22082230-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2015-11-19. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Degarelix as a new antiangiogenic agent for metastatic colon cancer?</title><link>https://peptidescanner.com/stories/pubmed-pmid-23431078-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23431078-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-23431078-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-10-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>In vitro and in vivo human metabolism of degarelix, a gonadotropin-releasing hormone receptor blocker.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23589543-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23589543-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-23589543-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-02-12. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Management of a patient with locally advanced prostate cancer with degarelix: a case report.</title><link>https://peptidescanner.com/stories/pubmed-pmid-23783053-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-23783053-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-23783053-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2013-06-20. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Tipping the balance in favour of degarelix for ADT.</title><link>https://peptidescanner.com/stories/pubmed-pmid-24473414-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-24473414-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-24473414-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-10-21. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A cost-utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom.</title><link>https://peptidescanner.com/stories/pubmed-pmid-24568188-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-24568188-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-24568188-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-01-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Gonadotropin-releasing hormone receptor-targeted paclitaxel-degarelix conjugate: synthesis and in vitro evaluation.</title><link>https://peptidescanner.com/stories/pubmed-pmid-25851250-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-25851250-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-25851250-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2015-06-23. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-27756786-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-27756786-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-27756786-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2017-11-07. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Degarelix versus luteinizing hormone-releasing hormone agonists for the treatment of prostate cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-28480768-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28480768-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-28480768-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2024-07-28. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Factors Predicting the Off-treatment Duration in Patients with Prostate Cancer Receiving Degarelix as Intermittent Androgen Deprivation Therapy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-28753747-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28753747-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-28753747-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2018-12-17. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>An efficient synthesis of deuterium-labeled degarelix acetate, a third-generation gonadotropin-releasing hormone receptor antagonist.</title><link>https://peptidescanner.com/stories/pubmed-pmid-28960413-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-28960413-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-28960413-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2019-09-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-29264358-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29264358-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-29264358-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-03-11. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A Phase II, Randomized, Multicenter Study Comparing 10 Months versus 4 Months of Degarelix Therapy in Prolonging the Off Treatment Interval in Men with Localized Prostate Cancer Receiving Intermitten…</title><link>https://peptidescanner.com/stories/pubmed-pmid-29534997-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-29534997-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-29534997-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-11-22. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Prostate Cancer Drug Degarelix Rapidly Treats Pedophilic Disorder.</title><link>https://peptidescanner.com/stories/pubmed-pmid-32573666-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-32573666-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-32573666-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2020-06-26. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>A Real-Time NMR Method for Measurement of In Vitro Aggregation Kinetics Of Degarelix Drug Products.</title><link>https://peptidescanner.com/stories/pubmed-pmid-33586081-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-33586081-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-33586081-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2021-03-24. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Degarelix for treating advanced hormone-sensitive prostate cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-34350976-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-34350976-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-34350976-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-06-23. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>[Treatment of advanced hormone-sensitive prostate cancer using degarelix].</title><link>https://peptidescanner.com/stories/pubmed-pmid-34907463-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-34907463-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-34907463-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-10-10. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Randomized Phase 2 Trial of Abiraterone Acetate Plus Prednisone, Degarelix, or the Combination in Men with Biochemically Recurrent Prostate Cancer After Radical Prostatectomy.</title><link>https://peptidescanner.com/stories/pubmed-pmid-34934969-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-34934969-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-34934969-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-07-16. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Patients and physician satisfaction of Degarelix in androgen deprivation therapy for advanced hormone-dependent prostate cancer in the Netherlands.</title><link>https://peptidescanner.com/stories/pubmed-pmid-35069083-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-35069083-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-35069083-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2022-04-30. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Degarelix vs. leuprorelin for the treatment of prostate cancer in China: A cost-utility analysis.</title><link>https://peptidescanner.com/stories/pubmed-pmid-35923949-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-35923949-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-35923949-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2025-10-31. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Investigation of the GnRH antagonist degarelix isomerization in biological matrices.</title><link>https://peptidescanner.com/stories/pubmed-pmid-37455491-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-37455491-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-37455491-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2023-07-19. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.</title><link>https://peptidescanner.com/stories/pubmed-pmid-38413843-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-38413843-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-38413843-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-07-24. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Resting state functional connectivity in paedophilic disorder and degarelix treatment.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41918172-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41918172-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-41918172-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-14. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item><item><title>Fatal Interstitial Pneumonitis During Combined Degarelix, Darolutamide, and Docetaxel Therapy for Metastatic Prostate Cancer.</title><link>https://peptidescanner.com/stories/pubmed-pmid-41970125-degarelix/</link><guid isPermaLink="false">urn:peptidescanner:story:pubmed-pmid-41970125-degarelix:v1:current</guid><atom:link href="https://peptidescanner.com/evidence/v1/peptides/degarelix.json#pubmed-pmid-41970125-degarelix-v1" rel="alternate" type="application/json"/><description>Lifecycle state current; Literature metadata; date in source 2026-08-13. PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article&apos;s findings.</description><dc:date>2026-11-15</dc:date><category>Literature metadata</category><category>Lifecycle state: current</category></item></channel></rss>
